Virchows Archiv
Journal Abbreviation: VIRCHOWS ARCH
ISSN: 0945-6317
eISSN: 1432-2307
Publisher: Springer Verlag (Germany)
Publications (121)
Tumour immune microenvironment drives prognostic relevance correlating with bladder cancer subtypes (2019)
Eckstein M, Strissel P, Pfannstiel C, Chiappinelli K, Sikic D, Wach S, Taubert H, et al.
Conference contribution
MUC4 as a potential marker for differentiating MASC and PLGA in minor salivary glands (2019)
Taverna C, Franchi A, Santucci M, Baneckova M, Skalova A, Agaimy A
Conference contribution
Glomerular disease associated with myeloproliferative and myelodysplastic/myeloproliferative neoplams (2019)
Büttner-Herold M, Sticht C, Wiech T, Porubsky S
Conference contribution
Frequency of GNAS mutation in intramuscular myxoma (2019)
Erber R, Stöhr R, Haller F, Hartmann A, Agaimy A
Conference contribution
Immunohistochemical TP53 expression in atypical fibroxanthoma and their mimics (2019)
Erber R, Hartmann A, Agaimy A
Conference contribution
Challenging the prognostic impact of the new WHO and TNM classifications with special emphasis on HPV status in penile carcinoma (2019)
Hölters S, Khalmurzaev O, Pryalukhin A, Loertzer P, Janssen M, Heinzelbecker J, Ueberdiek S, et al.
Journal article
Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder (2019)
Erben P, Sikic D, Wirtz RM, Martini T, Weis CA, Breyer J, Otto W, et al.
Journal article
Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme (2019)
Ohashi R, Martignoni G, Hartmann A, Caliò A, Segala D, Stöhr C, Wach S, et al.
Journal article
Multicentric analytical comparability study of programmed death-ligand 1 expression on tumor-infiltrating immune cells and tumor cells in urothelial bladder cancer using four clinically developed immunohistochemistry assays (2019)
Schwamborn K, Ammann JU, Knüchel R, Hartmann A, Baretton G, Lasitschka F, Schirmacher P, et al.
Journal article
BRAF mutation testing in melanoma: results from a German observational multicenter study (2019)
Hartmann A, Schirmacher P, Sterlacci W, Koch W, Liesenfeld DB, Schif B, Garbe C
Journal article